Macimorelin (Ghryvelin)

Status:
Do Not Prescribe (DNP)
Decision Date:
July 2022
 

Comments

60mg granules for oral suspension in sachet. Diagnosis of growth hormone deficiency in adults. ICB commissioned.

Do Not Prescribe (DNP) Drug Classifications

  • 1: Are classified by the BNF as 'less suitable for prescribing', and includes anti-malarials (where a private prescription may be provided). Have a lack of data on effectiveness compared with standard therapy

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app